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bjectives The objective of this study was to examine the effects of septal ablation on diastolic
unction with the use of invasive hemodynamics.
ackground Septal ablation is an alternative therapy for patients with obstructive hypertrophic car-
iomyopathy (HCM). However, its beneﬁcial effect on diastolic function, by relieving the systolic con-
raction load, may be countered by adverse effects from the infarction on left ventricular mechanics.
ethods Using high-ﬁdelity, micromanometer-tipped catheters, we examined 40 HCM patients by
aking direct measurements of the left ventricular outﬂow tract (LVOT) gradient, time constant of
yocardial relaxation (tau), and left atrial pressure (LAP) before and after septal ablation.
esults Although there was an overall reduction in LVOT gradient, septal ablation resulted in vari-
ble changes in myocardial relaxation and left atrial pressure. In 20 patients (50%), LAP increased.
he magnitude of LVOT gradient reduction directly correlated with the effects of septal ablation on
AP (R  0.58; p  0.0001). Those patients with a greater decrease in the LVOT gradient had better
mprovement in direct LAP. Furthermore, those patients with a larger decrease in left ventricular
utﬂow tract gradient had a beneﬁcial enhancement of ventricular relaxation, as measured by tau
R  0.43; p  0.006). Thus, the beneﬁcial enhancement of relaxation was directly related to im-
rovement in LAP (R  0.75; p  0.0001).
onclusions Septal ablation results in variable effects on left ventricular ﬁlling pressure, which are
ependent upon the magnitude of reduction in the LVOT gradient. These effects are mediated in
art by effects of ablation on myocardial relaxation. These ﬁndings shed insight into the pathophysi-
logic effects of septal reduction therapy in patients with HCM. (J Am Coll Cardiol Intv 2008;1:
52–60) © 2008 by the American College of Cardiology Foundation
rom the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
ichael A. Kutcher, MD, FACC, served as Guest Editor for this paper.anuscript received March 27, 2008; revised manuscript received July 8, 2008, accepted July 11, 2008.
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553iastolic dysfunction is a prominent, complex phenomenon
n patients with hypertrophic cardiomyopathy (HCM) that
rises from an interplay of multiple interrelated factors.
entricular relaxation plays a major role in diastolic filling
nd is dependent upon myocardial nonuniformity, pertur-
ations in sarcomere inactivation, and altered loading con-
itions (1–4). Each of these components can be exacerbated
y obstruction of the left ventricular outflow tract (LVOT),
hich leads to symptoms of heart failure and, in some
tudies, impaired survival (1–5). Likewise, as a therapeutic
arget, alleviation of LVOT obstruction could alter diastolic
unction in patients with HCM. However, few studies have
irectly examined the effect of septal reduction on myocar-
ial relaxation and overall diastolic function of the left
entricle (6–8).
Percutaneous septal ablation is an alternative therapy that
as been shown to relieve LVOT obstruction in patients
ith HCMs, leading to significant improvement in both
ymptoms and objective measures of functional capacity
9–12). Nonetheless, despite its early success, there has been
oncern regarding the consequences of induction of a
yocardial infarction in patients with HCM (13,14). In-
arction of myocardium may exacerbate diastolic dysfunc-
ion as the result of an increase in myocardial stiffness as well
s enhancement of ventricular nonuniformity.
These detrimental effects may be of particular importance
n patients with HCM who have hypertrophied noncompli-
nt ventricles and are inherently predisposed to nonunifor-
ity of both contraction and relaxation due to abnormal
yofibril structure and function. Conversely, improvement
n left ventricular filling pressures might occur if a large
ystolic contraction load is the predominant etiology for
iastolic dysfunction and can be reduced by septal ablation.
ccordingly, the objectives of the present study were to
xamine the effects of septal ablation on diastolic function in
atients with HCM using invasive hemodynamics.
ethods
tudy population. The Institutional Review Board ap-
roved this study. All participants provided informed con-
ent. The study population consisted of 48 patients with
bstructive HCM (LVOT gradient either 40 mm Hg at
est and/or 50 mm Hg during provocation) and normal
inus rhythm who presented to the Mayo Cardiac Cathe-
erization Laboratory for septal ablation. Patients who had
ndergone a previous surgical myectomy, were diagnosed
ith moderate or greater aortic valvular disease, had signif-
cant intrinsic mitral disease, had left ventricular ejection
raction 50%, had coronary artery stenosis 30%, or had
acemaker dependency (before or after septal ablation) were
ot included.
The diagnosis of HCM was based on typical clinicaleatures with ventricular myocardial hypertrophy occurring an the absence of any other cardiac or systemic disease that
ould have been responsible for the hypertrophy (15,16).
he magnitude of myocardial hypertrophy was assessed
ith M-mode and 2-dimensional transthoracic echocardi-
graphy with the use of standard techniques. Doppler
chocardiography was used to ascertain the peak LVOT
radient (17). Mitral regurgitation was graded semiquanti-
atively with the use of Doppler echocardiography and
olor-flow imaging (grade I, mild; grade II, moderate; grade
II, moderate-severe; grade IV, severe) (18).
emodynamic evaluation. Before receiving septal ablation,
ach patient underwent a comprehensive hemodynamic
valuation with cardiac catheterization completed under
onscious sedation in the fasting state. Transeptal puncture
ith placement of an 8-F Mullins sheath was performed
or direct measurement of left atrial pressure (LAP) and
eft ventricular (LV) pressure. Simultaneous ascending
ortic pressures with 6-F guide catheters were obtained
ia retrograde femoral access. Calibrated, high-fidelity,
icromanometer-tipped catheters (Millar Instruments,
ouston, Texas) were placed
nto the cardiac chambers. Rapid
cquisition (5-ms intervals) dig-
tal records were obtained from 3
o 5 end-expiratory cardiac cy-
les (19).
The following LV variables
ere measured: minimum dia-
tolic pressure, LV end-diastolic
ressure (EDP), mean LV dia-
tolic pressure (measured during
V diastolic filling period), LV
re-A pressure, and the rate of
ncrease (i.e., positive) and de-
rease (i.e., negative) in LV pressure (dp/dt) (19). From the
eft atrium, the following variables were measured: mean
AP, peak A wave pressure, peak V wave pressure, and V
ave height. V wave height was defined as the pressure
ifference between the peak V wave and the nadir of the x
escent in the left atrial pressure tracing (Fig. 1) (19).
The time constant of myocardial relaxation (tau) was
alculated by use of a zero asymptote method as described
y Weiss et al. (20). As described previously, tau is defined
s the negative inverse of the slope of the natural logarithm
f pressure versus time during the isovolumic relaxation
eriod. After a period of stabilization after septal ablation
15 min), this hemodynamic evaluation was repeated with
he same methodology. Baseline cardiac medications were
ontinued unchanged throughout the study. No intravenous
r oral fluid administration was performed during the
rocedure apart from that required to deliver intravenous
edatives and analgesics.
eptal ablation procedure. Septal ablation was performed in
Abbreviations
and Acronyms
EDP  end-diastolic pressure
HCM  hypertrophic
cardiomyopathy
LAP  left atrial pressure
LV  left ventricle
LVOT  left ventricular
outflow tract
tau  time constant of
myocardial relaxationll patients with the use of previously described techniques
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55421,22). In brief, an oversized, over-the-wire angioplasty
alloon was placed in the septal perforator artery from a left
oronary guide catheter using standard methods. After
alloon inflation, angiographic and echocardiographic con-
rast was injected through the balloon catheter to identify
he perfusion bed of the septal perforator. After delineation
f the targeted myocardium with contrast, 1 to 2 ml of
esiccated ethanol was infused over the course of 3 min to
min followed by a normal saline flush. For patients with
50% reduction in either the resting or provoked LVOT
radient, other septal arteries were targeted and treated in
imilar fashion. As a precaution against the development of
trioventricular block, all patients underwent temporary
acemaker placement during the procedure. Hemodynamic
valuations were completed in each patient during normal
inus rhythm.
ata analysis. To facilitate comparisons of hemodynamic
ariables before and after septal ablation, only patients who
emained in sinus rhythm were examined. Eight patients
17%) who underwent baseline evaluation were not further
nalyzed because of the need for continuous pacing after
eptal ablation. Significant resting obstruction was defined
s an LVOT gradient at rest of 40 mm Hg. Simple
egression analyses were performed with Statview 4.0 (SAS
nstitute, Cary, North Carolina). Comparisons of continu-
Figure 1. Method for Pressure Recording Analysis
Left atrium (LA), left ventricle (LV), and ascending aorta (Ao) demonstrating
the hemodynamic variables used for characterization of diastolic function.
(a) Minimum LV pressure; (b) LV pre-A pressure; (c) end-diastolic pressure,
LV end-diastolic pressure; (d) LV diastolic ﬁlling period; (e) LA peak A wave
pressure; (f) V wave height; (g) LA peak V wave pressure; (h) isovolumic
relaxation period.us variables were made with a 2-sample t test when theariable distributions were normally distributed, and a
ilcoxon rank sum or Mann-Whitney U test otherwise.
aired t tests or Wilcoxon rank sum test was used for
ithin-group comparisons; unpaired t tests or Mann-
hitney U test was used for between-group comparisons.
ontinuous variables are reported with one standard devi-
tion. Statistical significance was set at p  0.05.
esults
atient population. Mean age of the study population was
9  12 years (Table 1). Eight patients had a history of
trial fibrillation but were in normal sinus rhythm during
he study. The baseline LVOT gradient was either40 mm
g at rest (n  27) or 50 mm Hg with provocation in all
atients. Mean LAP at baseline was 17.7  7.2 mm Hg,
ith 33 patients (83%) having LAP 10 mm Hg. The
aseline LAP (R  0.49; p  0.001), peak V wave (R 
.57; p  0.0001), and V wave height (R  0.57; p 
.0001) all were related to the severity of the LVOT
radient. The median dose of ethanol administered was 1.8
0.5 ml.
he LVOT gradient reduction and left atrial pressure. Septal
blation significantly reduced the resting LVOT gradient
60.8  41.4 mm Hg to 10.8  15.7 mm Hg; p  0.0001)
Table 2). For the 13 patients with significant LVOT
radients who presented only with provocation, ablation
Table 1. Baseline Clinical Variables
Age, yrs 59 12
Male gender, n (%) 25 (63)
NYHA functional class III, n (%) 39 (98)
CCS class III, n (%) 15 (38)
Presyncope or syncope, n (%) 17 (43)
Family history of HCM, n (%) 9 (23)
Asymmetric pattern of hypertrophy, n (%) 25 (63)
Concentric pattern of hypertrophy, n (%) 15 (37)
Maximum ventricular wall thickness, mm 19.6 3.8
Interventricular septum, mm 19.5 3.9
Posterior wall, mm 13.3 3.4
End-diastolic diameter, mm 45.7 5.5
End-systolic diameter, mm 25.4 4.2
Left atrial volume index, ml/m2 38.2 11.5
Left ventricular ejection fraction, % 72 5
History of atrial ﬁbrillation, n (%) 8 (20)
Internal cardioverter-deﬁbrillator, n (%) 1 (3)
Medications, n (%)
Beta-receptor antagonist 26 (65)
Calcium-channel blocker 15 (37)
Disopyramide 2 (5)
ACE inhibitor or ARB 4 (10)
Amiodarone 5 (13)
ACE  angiotensin-converting enzyme; ARB  angiotensin-receptor blocker; CCS  CanadianCardiac Society; HCM hypertrophic cardiomyopathy; NYHA New York Heart Association.
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555educed the provoked gradient from 112 45 mmHg to 20
32 mm Hg (p  0.0001). The mean reduction in the
esting LVOT gradient was 83.2  21.8%, including 32
atients who had a reduction of 80%.
Although reduction in the LVOT gradient occurred in
he majority of patients, the effects of septal ablation on
AP were variable with a broad range of effect (12 mm
g to 18 mm Hg) (Fig. 2). There was no significant
hange in LAP in the overall population. The LAP in-
reased after septal ablation in 20 patients (50%). In the
emaining patients, there was either no change (n  4, or
0%) or a decrease in LAP (n  16, or 40%). The effect of
eptal ablation on LAP was directly related to the magni-
ude of reduction in LVOT gradient (R  0.58; p 
.0001). The relation of LVOT gradient reduction and
AP change remained evident (R  0.52; p  0.006) in
nalyses that excluded patients who had significant resting
VOT obstruction.
yocardial relaxation. Mean tau at baseline was 59  15
s, with 38 patients (95%) having tau 35 ms. After septal
blation, there was a mild prolongation of tau to 61 13 ms
n the overall study population (p  0.16 vs. baseline).
eptal ablation resulted in an increase in tau in 22 patients
55%), and either no change (n  2, or 5%) or a decrease (n
16, or 40%) in tau in the remaining patients. Similarly,
inimum left ventricular pressure increased in 20 patients
50%), and remained either unchanged (n  2, or 5%) or
ecreased (n  18, or 45%) after septal ablation in the
emaining patients.
The magnitude of reduction in the LVOT gradient was
irectly related to the effect of septal ablation on myocardial
Table 2. Baseline and Post-Procedural Invasive Hemodynamic Data
Variable Baseline
Systolic blood pressure, mm Hg 123 25
Diastolic blood pressure, mm Hg 70 10
Heart rate, beats/min 67 14
Left atrial pressure, mm Hg 17.7 7.2
LV pre-A pressure, mm Hg 17.9 5.1
Peak A wave pressure, mm Hg 26.6 8.0
Peak V wave pressure, mm Hg 26.6 8.0
V wave height, mm Hg 14.0 9.0
Minimum LV pressure, mm Hg 14.2 4.9
Mean LV diastolic pressure, mm Hg 18.9 5.9
LV end-diastolic pressure, mm Hg 24.2 7.1
Peak positive dp/dt 1,468 411
tau (ms) 58.5 15.1
Invasive LVOT gradient, mm Hg
Resting 60.8 41.4
Post-PVC 134.5 52.4
dp/dt  rate of increase and decrease in left ventricular pressure; LV  left ventricular; LVOT  le
relaxation.elaxation, as gauged by change in tau (R  0.43; p  a.006) and change in minimum left ventricular pressure (R
0.56; p 0.0002) (Figs. 3 and 4). Furthermore, the effect
f septal ablation on myocardial relaxation was directly
elated to the change in LAP (Fig. 3). The regression
oefficient for change in tau versus change in LAP was R 
.75 (p  0.0001). Overall, both worsening of myocardial
elaxation (measured by tau) and an increase in LAP
ccurred in 18 patients (45%).
redictors of Change in LAP With Septal Ablation
aseline LVOT gradient, myocardial relaxation indices (tau
nd minimum left ventricular pressure), and ventricular
lling pressures (LAP, mean diastolic pressure, LV pre-A
ressure, EDP) were related to change in LAP (Table 3).
he greater the LVOT gradient at rest, the greater the
entricular filling pressure, and a greater change in LAP. In
ddition, for patients whose baseline LAP was 20 mm
g, the LVOT gradient decreased 69  38 mm Hg and
AP change was 3.3  4.8 mm Hg.
Conversely, for patients whose baseline LAP was 20
m Hg, the LVOT gradient decreased 35  31 mm Hg
p  0.004 vs. baseline LAP 20 mm Hg) and LAP
hange was 3.5  4.9 mm Hg (p  0.0001 vs. baseline
AP 20 mm Hg). The change in LAP was not related to
he pre-procedural severity of mitral regurgitation (p 0.45
or LAP change, grade I/II vs. grade III/IV). Patients with
igh LVOT gradients had a decrease in LAP irrespective of
he severity of mitral regurgitation (Fig. 5). Variables of
yocardial hypertrophy, ventricular cavity size, and LA size
ere not predictive of the change in LAP after septal
Post-Procedural p Value
144 25 0.0001
76 15 0.0001
66 13 0.29
18.1 5.1 0.67
18.7 5.0 0.38
25.3 6.3 0.25
25.3 6.3 0.009
10.4 5.6 0.002
15.3 3.8 0.12
19.1 4.3 0.76
25.1 7.2 0.36
1,364 320 0.23
60.9 12.6 0.16
10.8 15.7 0.0001
44.3 46.4 0.0001
icular outflow tract; PVC  premature ventricular contraction; tau  time constant of myocardialft ventrblation.
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556iscussion
he principal findings of this study are as follows: 1) The
ffects of septal ablation on LAP are variable; 2) these effects
n LAP are directly related to the magnitude of LVOT
radient reduction; 3) changes in LAP from septal ablation
re mediated, at least in part, by the effects of ablation on
yocardial relaxation; and 4) improvement in LAP from
eptal ablation may occur independently of the baseline
everity of mitral regurgitation.
Diastolic dysfunction is a complex phenomenon that has
een described in a variety of cardiac disease states, but its
resence in HCM is associated with a complex interplay of
ultiple interrelated events that are unique to these pa-
ients. These processes include abnormal myocardial stiff-
ess due to myocardial hypertrophy and interstitial fibrosis,
yocardial ischemia from microvascular disease and abnor-
al coronary flow reserve, viscoelastic forces on the myo-
ardium, concomitant mitral regurgitation, and prolonga-
ion of ventricular relaxation. Obstruction of the LVOT
ay exacerbate diastolic dysfunction by increasing myocar-
ial ischemia, creating severe secondary mitral regurgitation,
nd adversely affecting ventricular relaxation (1–4). Current
herapies for septal reduction, namely, surgical myectomy
nd percutaneous septal ethanol ablation, are highly effica-
ious at relieving LVOT obstruction and related mitral
egurgitation. Less clear, however, is the impact of these
herapies on diastolic function. In particular, septal ablation,
hich is being used increasingly, relies on induction of
yocardial infarction for its efficacy (9–12). By simulta-
eously altering ventricular load and increasing nonunifor-
ity, septal ablation potentially affects several pathophysi-
logic processes that contribute to diastolic dysfunction in
pposite ways (4).
In patients with HCM who undergo surgical or percu-
aneous septal reduction therapy, relief of the systolic
ontraction load (i.e., LVOT obstruction), may beneficially
ffect LV filling pressures. Although the effects of septal
blation on LAP were highly variable, the present investi-
ation demonstrates that the effects on LAP are directly
elated to the baseline severity and extent of the reduction in
he LVOT gradient. The relation between LVOT gradient
eduction and LAP also remained evident in analyses that
xcluded patients without significant resting gradients.
hese data therefore demonstrate that the magnitude and
elief of systolic contraction load directly impact the net
ffects of septal ablation on diastolic function. Successful
eduction of high LVOT gradients with septal ablation
esults in a net lusitropic effect. Conversely, septal ablation
hat results in relatively small- or no-decreases in systolic
ontraction load either have no benefit or may acutely
orsen diastolic dysfunction.
Variable effects on myocardial relaxation from septalFigure 2. Effect of Septal Ablation on the LVOT Gradient
(A) Change in left ventricular outﬂow tract (LVOT) gradient with septal ablation,
(B) change in left atrial pressure (LAP) with septal ablation, and (C) the relation
between change in LVOT gradient and change in LAP with septal ablation. Septal
ablation resulted in variable effects on left atrial pressure, which correlated with
the extent of LVOT gradient reduction. Closed circles  patients with resting
LVOT gradients of 40 mm Hg; open circles  patients with resting LVOT gradi-blation also help to explain the observed different effects on
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557entricular filling pressure. Approximately 50% of patients
ad acute worsening of myocardial relaxation and LAP. In
ome patients undergoing septal ablation, enhancement of
entricular nonuniformity by myocardial infarction there-
ore may overwhelm the beneficial effects on diastolic
unction afforded by relief of LVOT obstruction (23).
hose patients with milder degrees of LVOT obstruction
nd diastolic dysfunction may be particularly sensitive to
nhancement of ventricular nonuniformity by septal abla-
ion, because an increase in LAP occurred more commonly
n these patients. These observations suggest septal ablation
ay be relatively more advantageous in patients in whom
here is severe LVOT obstruction and associated myocardial
elaxation abnormalities that may be exacerbated by patho-
ogic loading conditions. In those patients, septal ablation
ay have greater salutary effects on ventricular filling
ressures.
In patients with HCM, increased systolic contraction
oad from LVOT obstruction may alter myocardial relax-
tion through enhancement of regional asynchrony or non-
niformity, myocardial ischemia, and effects on fiber short-
ning and intracellular calcium ion handling (4,23).
Figure 3. Effect of LVOT Gradient Reduction on Myocardial Relaxation and
The effect of septal ablation on minimum left ventricular pressure (A) and the
left ventricular outﬂow tract (LVOT) gradient reduction. Furthermore, the effec
changes in left atrial pressure from septal ablation (C and D). Closed circles 
with resting LVOT gradients of 40 mm Hg.ynamic mitral regurgitation also frequently accompanies sbstructive HCM, and may lead to elevation in ventricular
lling pressures. In few previous studies, both pharmaco-
herapy and surgical myectomy for LVOT obstruction have
een associated with improved myocardial relaxation and
ecreases in ventricular filling pressure (24–26).
In the present investigation, the extent of reduction in the
ystolic LVOT gradient correlated with changes in myocar-
ial relaxation as assessed by tau and minimum LV pressure,
hich serves as a surrogate of ventricular diastolic suction.
oreover, the positive or negative changes in myocardial
elaxation from septal ablation were directly related to the
hanges in LAP. Certainly, greater dynamic mitral regur-
itation may be more common in those with relatively more
evere LVOT obstruction.
However, decreases in LAP were observed in one-third
f the patients with mild or moderate mitral regurgitation,
nd LAP change was not different according to the baseline
everity of mitral regurgitation. A 80% reduction in the
VOT gradient occurred in 80% of patients, suggesting
hat improvement of dynamic mitral regurgitation occurred
n the vast majority of patients. Furthermore, the authors of
revious studies (27–29) have demonstrated that greater
trial Pressure
constant of mycardial relaxation (tau) (B) varied according to the extent of
inimum left ventricular pressure and tau were directly related to the
nts with resting LVOT gradients of 40 mm Hg; open circles  patientsLeft A
time
ts on m
patieeverity of mitral regurgitation results in enhanced ventric-
u
r
p
c
p
a
o
L
t
a
r
o
g
e
t
i
u
d
g
m
t
e
d
a
u
1.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 1 , N O . 5 , 2 0 0 8
O C T O B E R 2 0 0 8 : 5 5 2 – 6 0
Sorajja et al.
Ablation and Diastolic Function
558lar relaxation (i.e., lower tau); therefore, relief of mitral
egurgitation would not lead to lusitropic effects in the
resent study. In the study herein, the decrease in LAP
orrelated closely with a decrease in LV minimum diastolic
ressure, supporting the contribution of changes in relax-
tion rather than mitral regurgitation. Thus, although relief
f dynamic mitral regurgitation may lead to improvement in
AP, the high-fidelity measures of LV pressure decay in
his study suggest that the effects of septal ablation on LAP
re mediated, at least in part, by alterations in myocardial
elaxation from relief of systolic contraction load.
Ideal therapy for diastolic dysfunction in patients with
bstructive HCM would relieve the burden of the LVOT
Figure 4. Sample Hemodynamic Tracings From 4 Patients Before and After
(A) The patient was a 56-year-old woman with a marked increase in the le
decreases in tau (the time constant of myocardial relaxation), minimum lef
man with a left ventricular outﬂow tract gradient of 113 mm Hg, septal ab
and D) Two patients (a 71-year-old man and a 67-year-old man, respective
tion resulted in acute prolongation of tau and elevation in ventricular ﬁllin
minimum left ventricular diastolic pressure; other abbreviations as in Figureradient without affecting ventricular nonuniformity or ixacerbating other components of diastolic function. Al-
hough there was a net salutary effect on diastolic function
n some patients, persistent or enhanced ventricular non-
niformity from septal ablation may have obviated further
ecrement in LAP. Surgical myectomy is considered the
old standard for septal reduction therapy, and theoretically
ay have a less adverse effect on ventricular nonuniformity
han septal ablation (13).
Nonetheless, analogous to the present study, the clinical
fficacy of surgical myectomy also has been found to be
irectly related to operative reduction in LVOT gradient
nd EDP (30). Furthermore, persistent ventricular non-
niformity has been proposed as a mechanism for continued
al Ablation
tricular outﬂow tract gradient. After septal ablation, there were acute
ricular pressure, and left atrial pressure. (B) Similarly, in this 62-year-old
resulted improvement in myocardial relaxation and left atrial pressure. (C
o had relatively lower left ventricular outﬂow tract gradients. Septal abla-
sures in both of these patients. LAP  left arterial pressure; LV-MIN Sept
ft ven
t vent
lation
ly) wh
g presmpaired exercise capacity after surgical myectomy (31).
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559tudy limitations. The acute nature of this hemodynamic
tudy restricted the ability to examine the long-term
onsequences of change in diastolic function that resulted
rom septal ablation. Infarct-related remodeling occurs
fter ablation (32). As the result of the absence of a
linical indication for repeat catheterization, further
haracterization of diastolic function with invasive means
n subsequent follow-up was not attempted. We did not
ursue chronic studies by using echocardiography because
he current noninvasive methods of examining diastolic
unction in patients with HCM are of limited accuracy
33). In addition, we did not believe it was ethical to
erform invasive cardiac catheterization on these patients
n follow-up. Thus, this investigation was limited to the
cute setting.
Second, because of the inherent difficulties in the
chocardiographic quantification of dynamic mitral re-
urgitation because of obstructive HCM, such measures
f mitral regurgitation were not undertaken. Third,
ariations in septal infarct size could contribute to the
bserved heterogeneity in the effects of septal ablation
Table 3. Regression Coefficients for the Relation Between Baseline
Variables and the Dependent Variable of Change in Left Atrial Pressure
After Ablation
Variable R p Value
Age 0.19 0.23
Maximal left ventricular wall thickness 0.25 0.12
Ventricular septal thickness 0.23 0.16
Posterior wall thickness 0.18 0.29
End-diastolic diameter 0.07 0.68
End-systolic diameter 0.10 0.57
Left atrial volume index 0.03 0.86
Ejection fraction 0.06 0.72
Resting gradient 0.53 0.0005
Provoked gradient (n  24) 0.47 0.02
Heart rate 0.10 0.54
Systolic blood pressure 0.10 0.54
Diastolic blood pressure 0.16 0.33
Peak positive dp/dt 0.08 0.63
Volume ethanol injected 0.01 0.95
LA peak A pressure 0.47 0.002
LA peak V pressure 0.64 0.0001
LA V wave height 0.52 0.0006
Minimum left ventricular pressure 0.56 0.0002
Left ventricular pre-A pressure 0.43 0.005
Mean left ventricular pressure 0.52 0.0005
Left ventricular end-diastolic pressure 0.63 0.0001
LA pressure 0.71 0.0001
Baseline tau 0.53 0.004
dp/dt rate of increase and decrease in left ventricular pressure; LA left atrial; R regression
coefficients.nd quantitative measures of infarct size were not sys-ematically performed. Finally, the present investigation
xamined diastolic function only in resting conditions
nd the effects of ablation on exercise-induced diastolic
ysfunction remain unknown.
Figure 5. Change in Left Atrial Pressure and Myocardial Relaxation
According to the Severity of LVOT Gradient and Baseline MR
Only 2 patients had LVOT gradient 50 mm Hg and grade III or IV mitral
regurgitation. However, as shown in (A), septal ablation led to decreases in
left atrial pressure in patients with gradient 50 mm Hg independently of
the severity of MR, whereas those patients with LVOT gradient 50 mm
Hg more commonly had increases in left atrial pressure. *p  0.002 and
**p  0.03 for comparison versus LVOT gradient 50 mm Hg and grade I
or II mitral regurgitation. Furthermore, as shown in (B), improvement in tau
(the time constant of myocardial relaxation) was observed in patients with
gradients 50 mm Hg independently of the severity of MR. However, pro-
longation of tau more frequently occurred in those patients with gradients
50 mm Hg. *p  0.006 and **p  0.03 for comparisons versus LVOT gra-
dient 50 mm Hg and grade I or II mitral regurgitation. All other compari-
sons were not statistically signiﬁcant. LVOT  left ventricular outﬂow tract;
MR  myocardial relaxation.
CB
s
f
i
t
r
c
s
r
R
2
r
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
K
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 1 , N O . 5 , 2 0 0 8
O C T O B E R 2 0 0 8 : 5 5 2 – 6 0
Sorajja et al.
Ablation and Diastolic Function
560onclusions
y using high-fidelity invasive measurements, we have
hown a variable effect of septal ablation on diastolic
unction in patients with HCM. There are several compet-
ng factors that determine the final effect on LAP, including
he relief of contraction load, effect on ventricular relaxation,
esidual degree of mitral regurgitation, as well as the primary
onsequence of the myocardial infarction. These findings
hed insight into the pathophysiological consequences of
elief of LVOT obstruction in patients with HCM.
eprint requests and correspondence: Dr. Rick A. Nishimura,
00 1st Street SW, Rochester, Minnesota 55906. E-mail:
ick.nishimura@mayo.edu.
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